Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the DNA

Details for Australian Patent Application No. 2002256633 (hide)

Owner EPIGENOMICS AG

Inventors Berlin, Kurt; Olek, Alexander

Agent Pizzeys

Pub. Number AU-A-2002256633

PCT Pub. Number WO2002/070741

Priority 60/272,484 01.03.01 US

Filing date 1 March 2002

Wipo publication date 19 September 2002

International Classifications

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

13 March 2003 Application Open to Public Inspection

  Published as AU-A-2002256633

24 January 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002256634-METHOD AND DEVICE FOR IMPROVING A DATA THROUGHPUT

2002256632-PRODRUGS DERIVATIVES OF THE ASCORBIC ACID SUITABLE TO THE PASSAGE OF THE HEMATOENCEPHALIC BARRIER